ATE225803T1 - Peptid zur verringerung des triglyzeridspiegels des blutes und inhibitor für den anstieg des triglyzeridspiegels des blutes, der das peptid als aktiven bestandteil enthält - Google Patents

Peptid zur verringerung des triglyzeridspiegels des blutes und inhibitor für den anstieg des triglyzeridspiegels des blutes, der das peptid als aktiven bestandteil enthält

Info

Publication number
ATE225803T1
ATE225803T1 AT96916354T AT96916354T ATE225803T1 AT E225803 T1 ATE225803 T1 AT E225803T1 AT 96916354 T AT96916354 T AT 96916354T AT 96916354 T AT96916354 T AT 96916354T AT E225803 T1 ATE225803 T1 AT E225803T1
Authority
AT
Austria
Prior art keywords
peptide
triglyceride levels
blood triglyceride
blood
well
Prior art date
Application number
AT96916354T
Other languages
English (en)
Inventor
Kyoichi Kagawa
Hisako Matsutaka
Chizuko Fukuhama
Hiroaki Fujino
Masahiro Numata
Kazuhisa Honda
Toyoo Nakamura
Original Assignee
Hankyu Kyoei Bussan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hankyu Kyoei Bussan Co Ltd filed Critical Hankyu Kyoei Bussan Co Ltd
Application granted granted Critical
Publication of ATE225803T1 publication Critical patent/ATE225803T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96916354T 1996-03-22 1996-06-10 Peptid zur verringerung des triglyzeridspiegels des blutes und inhibitor für den anstieg des triglyzeridspiegels des blutes, der das peptid als aktiven bestandteil enthält ATE225803T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8066916A JP2805194B2 (ja) 1996-03-22 1996-03-22 血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤
PCT/JP1996/001570 WO1997035875A1 (fr) 1996-03-22 1996-06-10 Peptide destine a inhiber l'elevation du taux de triglycerides dans le sang et agent d'inhibition contenant ce peptide en tant qu'ingredient actif

Publications (1)

Publication Number Publication Date
ATE225803T1 true ATE225803T1 (de) 2002-10-15

Family

ID=13329785

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96916354T ATE225803T1 (de) 1996-03-22 1996-06-10 Peptid zur verringerung des triglyzeridspiegels des blutes und inhibitor für den anstieg des triglyzeridspiegels des blutes, der das peptid als aktiven bestandteil enthält

Country Status (11)

Country Link
US (1) US5958885A (de)
EP (1) EP0838473B1 (de)
JP (1) JP2805194B2 (de)
KR (1) KR100264344B1 (de)
AT (1) ATE225803T1 (de)
AU (1) AU690853B2 (de)
CA (1) CA2221767C (de)
DK (1) DK0838473T3 (de)
ES (1) ES2184865T3 (de)
NO (1) NO325836B1 (de)
WO (1) WO1997035875A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000095794A (ja) * 1998-09-22 2000-04-04 Itoham Foods Inc エンケファリン分解酵素の阻害剤
JP2000264845A (ja) * 1999-02-04 2000-09-26 Nippon Synthetic Chem Ind Co Ltd:The コレステロール降下剤及びその用途
US7060467B2 (en) 2000-03-13 2006-06-13 Monsanto Technology Llc Recombinant proteins containing repeating units
DE10105041A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
US20070254889A1 (en) * 2001-04-23 2007-11-01 Lee-Way Jin Compounds and methods useful for rescuing cells from beta-amyloid toxicity and treatment of Alzheimer's disease
WO2003092614A2 (en) * 2002-05-02 2003-11-13 Hickle Randall S Lipid removal from the body
GB0211849D0 (en) * 2002-05-23 2002-07-03 Mok Kenneth H Improvments to retro-inverso isomers
NO322425B1 (no) * 2003-07-04 2006-10-02 Berge Biomed As Anvendelse av et hydrolysat av proteinholdig fiskemateriale for fremstilling av et farmasoytisk middel for behandling og/eller hindring av patologisk hoye nivaer av tracylglyceroler, hyperkolesterolemia, hyperhomocysteinemia, eller patologisk lave nivaer av beta-oksidasjon i et dyr eller menneske.
US20080063781A1 (en) * 2004-09-30 2008-03-13 Suntory Limited Globin Digest Containing, Yeast-Fermented Beverages
ES2328835T3 (es) * 2004-11-15 2009-11-18 Mg Pharma Inc. Hidrolizado de proteinas con efecto antidiabetico.
JP4395658B2 (ja) 2005-11-17 2010-01-13 エムジーファーマ株式会社 コレステロール再上昇抑制用組成物およびその用法
JP5175484B2 (ja) * 2007-03-30 2013-04-03 名古屋製酪株式会社 血中中性脂肪濃度上昇抑制剤
EP2179740B1 (de) * 2007-08-07 2014-10-08 Mg Pharma Inc. Wirkstoff gegen bluthochdruck
CN107556363B (zh) * 2016-06-30 2021-03-30 江西本草天工科技有限责任公司 肽或其盐及其制备方法
WO2018001273A1 (zh) * 2016-06-30 2018-01-04 江西本草天工科技有限责任公司 肽或其盐、其制备方法、及其制备预防和/或治疗肝损伤药物的用途
CN107551258B (zh) * 2016-06-30 2021-01-05 江西本草天工科技有限责任公司 用于预防和/或治疗肝损伤的vvyp

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723443A (en) * 1988-02-02 1998-03-03 Hankyu-Kyoei Bussan Co. Ltd. Lipid metabolism promoting agent and its use
CA1335567C (en) * 1988-02-02 1995-05-16 Kyoichi Kagawa Lipid metabolism promoting agent
JP2764276B2 (ja) * 1988-09-06 1998-06-11 仙味エキス株式会社 機能性新規ペプチド及びその利用
JPH0331298A (ja) * 1989-06-28 1991-02-12 Ajinomoto Co Inc プロリルエンドペプチターゼ阻害ペプチド
JPH03120224A (ja) * 1989-10-04 1991-05-22 Ajinomoto Co Inc 新規ペプチドおよびこれを含有する降圧剤
JP3312944B2 (ja) * 1993-03-24 2002-08-12 伊藤ハム株式会社 脂肪細胞分化抑制ペプチド及び当該ペプチドを有効成分とする脂肪細胞分化抑制剤
JP2800877B2 (ja) * 1993-12-28 1998-09-21 伊藤ハム株式会社 血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤

Also Published As

Publication number Publication date
AU5912096A (en) 1997-10-17
EP0838473A1 (de) 1998-04-29
ES2184865T3 (es) 2003-04-16
JPH09255698A (ja) 1997-09-30
NO975360D0 (no) 1997-11-21
CA2221767C (en) 2001-01-23
WO1997035875A1 (fr) 1997-10-02
US5958885A (en) 1999-09-28
EP0838473A4 (de) 2000-04-05
NO325836B1 (no) 2008-07-28
DK0838473T3 (da) 2003-02-17
CA2221767A1 (en) 1997-10-02
EP0838473B1 (de) 2002-10-09
KR19990021880A (ko) 1999-03-25
KR100264344B1 (ko) 2000-08-16
NO975360L (no) 1998-01-21
AU690853B2 (en) 1998-04-30
JP2805194B2 (ja) 1998-09-30

Similar Documents

Publication Publication Date Title
ATE225803T1 (de) Peptid zur verringerung des triglyzeridspiegels des blutes und inhibitor für den anstieg des triglyzeridspiegels des blutes, der das peptid als aktiven bestandteil enthält
KR960701089A (ko) 지방세포 분화 억제 펩타이드 및 그를 유효성분으로 포함하는 지방세포 분화 억제제
ATE222488T1 (de) Verwendung von anti-vegf-mitteln zur behandlung der endometriose
LV11719A (lv) Sastavs dzivnieku kautkermenu saglabasanas uzlabosanai
DE60305055D1 (de) Verwendung von ghrelin zur behandlung von unterernährung von gastrektomiepatienten
PT1011723E (pt) Factor de crescimento tumorigenico de 88 kda e antagonistas
DK0613499T4 (da) Humane IT-4-mutantproteiner
DE69835680D1 (de) Therapeutische verwendung von smr1 protein und seinen aktiven derivaten
Croom et al. Neuropeptide Y, peptide YY and aluminum in Alzheimer’s disease:: Is there an etiological relationship?
ATE183651T1 (de) Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen
DE69735883D1 (de) Methode zur behandlung von muskelkrankheiten
NO995692D0 (no) Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
FR2421565A1 (fr) Produit pouvant etre grille, frit ou roti a base de chair hachee
FI974601A (fi) Veren triglyseriditason kohoamista estävä peptidi ja mainittua peptidiä aktiivisena aineosana sisältävä veren triglyseriditason kohoamisen estäjä
Jansson et al. Acquired flexural deformity of the distalinterphalangeal joint in horses: Treatment by desmotomy of the accessory ligament of the deep digital flexor tendon: A retrospective study
CA2225412A1 (en) A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component
RU94001214A (ru) Способ получения животного белка для питания пушных зверей
EA200001131A1 (ru) Промотор гена вмр-4 человека и способ анализа с его использованием вещества, связанного с костной тканью
ATE218869T1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
UA85060C2 (ru) Биологически активная добавка к пище
RU96102950A (ru) Средство для лечения кожных заболеваний "карталин"
RU93052444A (ru) Лекарственный препарат бан

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0838473

Country of ref document: EP

REN Ceased due to non-payment of the annual fee